ONCOLOGY CLINICAL TRIALS EXPERTISE
ERT’s eClinical technology and service solutions help bring life-saving oncology drugs to patients faster. Our advanced data collection and analysis methods increase data quality, simplify patient participation and enable quicker, more informed decision making for both traditional and hybrid oncology trials.
Do you have the solutions you need to address oncology trial challenges?
The oncology drug pipeline has grown by nearly 70% since 2013. As sponsors look for cures in this evolving therapeutic area, they face many challenges, including an average success rate of only 3.4%.*
ERT’s eClinical technologies and therapeutic expertise provide relief to sponsors of all sizes who want to empower their study teams. Using our tools, your teams can be more productive, confident, and in control of the bedrock of your patient trial: endpoint data.
Choosing the right patient data capture technology increases your odds of sticking to timelines and budgets, enrolling the right patients, and collecting accurate, high-quality information.
How can I decentralize my oncology clinical trial using virtual technology?
What can I do to accelerate my oncology study?
How can I optimize site performance?
How can I maximize patient enrollment and retention?
How can I use technology to reduce data collection and monitoring complexity in my trial?
Oncology trials take 69% longer
Low site compliance and retention
Low patient enrollment
Increasing complexity with more endpoints
*Chi Heem Wong, Kien Wei Siah, Andrew W Lo. “Estimation of clinical trial success rates and related parameters.” Biostatistics 20(2): April 2019, Pages 273-286. Published online: 31 January 2018. DOI: 10.1093/biostatistics/kxx069
5 WEEKS TO FIRST PATIENT-IN WITH ERT eCOA
ERT’s library of pre-built commonly used eCOA oncology assessments gets you from study design to software release in just 5 weeks.
TAKE CONTROL OF STUDY PERFORMANCE
ERT’s Trial Oversight suite collects, normalizes, and analyzes trial data to uncover holistic insights into study performance, patient retention, and risk management. Our proven monitoring tools enable you to identify potential patient safety and study issues so you can make more informed, proactive decisions.
ERT ONCOLOGY EXPERIENCES
ERT’s centralized Cardiac Safety solution helps you maximize patient recruitment in oncology trials by ensuring only the correct patients are enrolled – and that none are incorrectly excluded.
ERT’s advanced imaging solution accelerates oncology trials by leveraging guided-read technology to minimize human error associated with important safety and efficacy data reads and overreads.
ERT’s Post-Approval patient data capture oncology solution is designed with longevity, simplicity and patient centricity in mind.
ERT’s eCOA solution gets you to first-patient-in 50% faster, accelerating study start-up. We also ensure that our solution is designed around the unique needs of cancer patients, simplifying participation and reducing the need for site visits and time spent at site.
This survey explores the acceptance of digital technology for clinical research amongst oncology patients.
Oncology Patient Data: Digital Health Preferences & MotivationsLEARN MORE
ERT’s eCOA solution provided efficient deployment of eCOA assessments across oncology studies in various indications.
High-Quality eCOA Data Across Group of Oncology StudiesLEARN MORE
Regulatory agencies are also placing weight on the importance of PRO-based secondary endpoints that are indicative of clinical benefit.
Patient-Reported Outcome (PRO) Data in Oncology TrialsLEARN MORE
This article presents how sponsors can optimize imaging processes in oncology clinical trials
Cardiac Imaging in Oncology TrialsLEARN MORE
Learn how relying on ECG machine QTc measurements during oncology trials can impact dosing decisions.
Benefits of Centralized ECGs in OncologyLEARN MORE
Learn how imaging evaluations (e.g. CT/MRI) can be used as outcome endpoints to determine efficacy in oncology clinical trials.
Oncology Imaging InnovationsLEARN MORE
Web portal provides ideal solution for 8-year, large scale observational study.
Pharma company adopts ‘light touch’ approach for multiple myeloma registryLEARN MORE
TALK TO A SPECIALIST
With decades and thousands of trials worth of experience, ERT has the knowledge and flexibility to provide proven eClinical technology solutions for your next oncology trial or post-approval study. To find out how our technology or services can fit your protocol, submit a contact form. A member of our team will be in touch with you shortly.